Abstract
Doxepin—like other antidepressant drugs (ADs)—shows a variable antidepressant effect in clinical practice. The cause for this variability is as yet unclear; however, pharmacokinetic factors such as the variable permeability of doxepin into the cerebrospinal fluid (CSF), may contribute to the difference in therapeutic efficacy. We measured and correlated the concentration of doxepin and its active metabolite nordoxepin in both the plasma and CSF. Plasma and CSF samples were taken simultaneously from 21 patients who were treated with doxepin due to different clinical indications. The plasma concentration of both doxepin and nordoxepin correlated significantly with the oral dosage of doxepin (doxepin: r = +0.66, p < 0.001; nordoxepin: r = +0.78, p < 0.0001; Spearman’s correlation). Furthermore, we found significant correlations between the plasma and CSF concentrations of both doxepin (r = +0.71; p < 0.001; Pearson’s correlation) and nordoxepin (r = +0.74; p < 0.001). These highly significant correlations between the plasma and CSF concentrations indicate a constant CSF permeability of doxepin and its active metabolite nordoxepin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumann P, Jonzier-Perey M, Paus E, Nikisch G (2006) Mirtazapine enantiomers in blood and cerebrospinal fluid. Neuropsychobiology 54(3):179–181
Benkert O, Hippius H (2000) Kompendium der Pschiatrischen Pharmakotherapie, 2nd edn. Springer, New York, pp 1–92
Bonati M, Kanto J, Tognoni G (1982) Clinical pharmacokinetics of cerebrospinal fluid. Clin Pharmacokinet 7(4):312–335
Deuschle M, Härtter S, Hiemke C, Standhardt H, Heuser I (1997) Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patients. Psychopharmacology 131(1):19–22
Hendset M, Haslemo T, Rudberg I, Refsum H, Molden E (2006) The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs. Pharmacopsychiatry 39(4):121–127
Nikisch G, Eap CB, Baumann P (2008) Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study. Pharmacol Res 58(5–6):344–347
Nikisch G, Baumann P, Oneda B, Kiessling B, Weisser H, Mathé AA, Yoshitake T, Kehr J, Wiedemann G, Eap CB (2010a) Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study. J Psychopharmacol doi: 10.1177/0269881110389208
Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé A (2010b) Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol 30(5):496–503
Nikisch G, Baumann P, Kiessling B, Reinert M, Wiedemann G, Kehr J, Mathé AA, Piel M, Roesch F, Weisser H, Schneider P, Hertel A (2010c) Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine. J Psychiatr Res 44(12):754–759
Nordin C, Bertilsson L (1995) Active hydroxymetabolites of antidepressants. Clin Pharmacokinet 28(1):26–40
Nordin C, Bertilsson L, Siwers B (1985) CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite. Br J Clin Pharmacol 20(4):411–413
Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J (2005) The choroid plexus-cerebrospinal fluid system: from development to aging. Curr Top Dev Biol 71:1–52
Sathananthan GL, Gershon S, Almeida M, Spector N, Spector S (1976) Correlation between plasma and cerebrospinal fluid levels of imipramine. Arch Gen Psychiatry 33(9):1109–1110
Strazielle N, Khuth ST, Ghersi-Egea JF (2004) Detoxification systems, passive and specific transport for drugs at the blood–CSF barrier in normal and pathological situations. Adv Drug Deliv Rev 56(12):1717–1740
Wellhöner HH (1997) Allgemeine und systematische Pharmakologie und Toxikologie, 6th edn. Springer, New York
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schomburg, R., Remane, D., Fassbender, K. et al. Doxepin concentrations in plasma and cerebrospinal fluid. J Neural Transm 118, 641–645 (2011). https://doi.org/10.1007/s00702-011-0613-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-011-0613-x